“We started working with the RNA team when we realized that the large branded firm that we were working with needed too much hand holding to understand our investments and the royalty industry. We switched to RNA because they understand the sector, are responsive and efficient, and are in the flow of the biopharma ecosystem.”
“The RNA team helped us from inception through our IPO and beyond. They are one of the top firms that I know of at the intersection of valuation, biotech and finance. I’d recommend them for my life science venture-backed company colleagues.”
“We have been working with RNA for several years. They are responsive, reliable, understand the nuances of our business and help us with modeling expertise that exceeds the capabilities within our corporate organization. We value them as an ecosystem partner and as a true extension of our operating team.”
“I’ve worked with the RNA team on a number of valuation matters, large and small. These guys know their stuff. Whether using them to assist with large licensing transaction negotiations to simple tax and financial reporting work, they understand and they deliver.”
RNA Advisors, LLC, a leading valuation and strategic... [read more]
Since 2015, RNA Advisors has provided valuation, transactional... [read more]
By Jeff Williamson THE SITUATION: A healthcare company... [read more]
By Jeff Suchocki, CFA The Situation: Adoption of... [read more]
By Jeff Williamson THE SITUATION: A medical device... [read more]
THE PROBLEM: A healthcare technology company that sells... [read more]
Jeff Williamson has joined the RNA Advisors growing... [read more]
THE PROBLEM: A publicly traded clinical stage biotech... [read more]
Enter your email address below to receive updates from RNA Advisors.